Eli Lilly

Eli Lilly, Boehringer roll out video game for doctors to highlight cardio-renal-metabolic disease connections
Fierce Pharma
Tue, 10/12/21 - 11:41 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
gamification
Eli Lilly’s recalled emergency diabetes drug came from plant cited by FDA
Reuters
Tue, 10/5/21 - 09:45 pm
Eli Lilly
diabetes
Glucagon Emergency Kits
drug manufacturing
product recalls
Lilly adds liver fat, CGM blood sugar data to mountain of evidence on hot diabetes prospect tirzepatide
Fierce Biotech
Thu, 09/30/21 - 10:58 am
Eli Lilly
tirzepatide
clinical trials
diabetes
HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations
Endpoints
Fri, 09/24/21 - 12:00 pm
HHS
340B
discounts
Novartis
Eli Lilly
AstraZeneca
Novo Nordisk
Sanofi
United Therapeutics
FDA approves Eli Lilly antibody cocktail for COVID-19 prevention
Beckers Hospital Review
Thu, 09/16/21 - 11:10 pm
Eli Lilly
Emergency Use Authorization
COVID-19
antibodies
FDA
CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push
Fierce Pharma
Thu, 09/16/21 - 10:50 am
drug pricing
Medicare
Pharma CEOs
Eli Lilly
AbbVie
Bristol Myers Squibb
Biogen
GSK
Eli Lilly Pursues RNA Editing in New Partnership with ProQR
Xtalks
Mon, 09/13/21 - 10:43 am
Eli Lilly
RNA
gene editing
ProQR Therapeutics
No joy for Ajovy: Teva's migraine drug can't find a win in meta-analysis versus Biohaven, AbbVie meds
Fierce Pharma
Thu, 09/9/21 - 11:11 am
Teva Pharmaceutical
Eli Lilly
Amgen
Ajovy
Biohaven
migraines
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation tech
Fierce Biotech
Thu, 09/9/21 - 11:08 am
Lycia Therapeutics
protein degradation
Eli Lilly
funding
Eli Lilly follows up MiNA pact with a 2nd $1B-plus RNA collab, this time with ProQR
Fierce Biotech
Wed, 09/8/21 - 11:28 pm
Eli Lilly
RNA
gene silencing
ProQR Therapeutics
Former Eli Lilly job applicants say the company's hiring practices favor the young
Fierce Pharma
Thu, 09/2/21 - 10:19 pm
Eli Lilly
age discrimination
It's back: Eli Lilly's COVID-19 antibody combo makes its return after 2 months on the sidelines
Fierce Pharma
Mon, 08/30/21 - 10:59 am
Eli Lilly
antibodies
COVID-19
Regeneron
GSK
bamlanivimab-etesevimab
Here's What This Label Expansion Could Mean for Eli Lilly Investors
Motley Fool
Sun, 08/29/21 - 11:16 pm
Eli Lilly
Jardiance
heart failure
label expansions
FDA
Backed by Eli Lilly, a little-known and secretive Chinese biotech fills the tank as it heads to the clinic
Endpoints
Fri, 08/27/21 - 10:57 am
China
Eli Lilly
Lilly Asia Ventures
Lynk Pharmaceuticals
Eli Lilly To Utilize Lycia's LYTAC Platform To Treat Challenging Disease Areas
NASDAQ
Wed, 08/25/21 - 11:18 am
Eli Lilly
Lycia Therapeutics
R&D
drug development
protein degradation
LYTACs
House committee questions Eli Lilly, Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high'
Endpoints
Fri, 08/20/21 - 12:31 pm
Eli Lilly
Sanofi
Novo Nordisk
insulin
diabetes
drug pricing
Jardiance gets parity with Farxiga in US as FDA clears use in heart failure
Pharmaforum
Wed, 08/18/21 - 11:43 pm
Eli Lilly
Boehringer Ingelheim
FDA
diabetes
Jardiance
heart failure with reduced ejection fraction
Lilly, with Alzheimer's in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec
Fierce Biotech
Tue, 08/17/21 - 10:26 am
Eli Lilly
reorganization
Loxo Oncology
oncology
Neuroscience
Alzheimer's disease
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug
BioSpace
Mon, 08/16/21 - 10:15 pm
Teva Pharmaceutical
patents
migraines
Ajovy
Eli Lilly
Emgality
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on
Fierce Biotech
Mon, 08/16/21 - 12:25 pm
Eli Lilly
lebrikizumab
Sanofi
Regeneron
Dupixent
atopic dermatitis
clinical trials

Pages